Experimental COVID-19 drug remdesivir at Our Lady of the Lake for expanded access program


BATON ROUGE, La. (LOCAL 33/FOX 44) – An experimental drug used as a possible treatment for the Coronavirus is now in Baton Rouge.

It’s called remdesivir and it was fast tracked by the FDA.

“The data shows that Remdesivir has a clear cut significant, positive effect in diminishing the time to recovery,” said Dr. Anthony Fauci, the Director of the National Institute of Allergy and Infectious Diseases.

The nation’s top infectious disease expert said patients treated with remdesivir had a 31% faster recovery rate, or four days, from COVID-19.

“We have to be looking at every possible avenue right now to treat it,” said Dr. Phillip Allen, Associate Chief Medical Officer at Our Lady of the Lake.

Our Lady of the Lake is currently the only hospital in the area with remdesivir.

Dr. Allen said, “Any drug we see that has promise, obviously we’re excited about investigating further.”

The drug is not going to everyone just yet. It’s going to the sickest patients in the hospital as part of an expanded access program. So far, ten patients are signed up for the program.

Remdesivir is an anti-viral drug developed back in 2013 to combat the Ebola virus. It comes in I.V. form, your doctor can’t prescribe it and it’s not a cure.

Dr. Allen is confident with all the research we will combat the Coronavirus.

Dr. Allen explained, “It’s so hard to maintain optimism right now. It’s tough, but there’s reason to be optimistic that we’re gonna win.”

Dr. Allen said right now the key is looking at every possible avenue for treatment and investigating new drugs because things keep changing with this virus.

Copyright 2020 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Latest BRProud Articles

More Local News

Stay up to date with the latest news by downloading the BRProud App from the App Store or Google Play.

Trending Stories